GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » Additional Paid-In Capital

PharmaResearch Co (XKRX:214450) Additional Paid-In Capital : ₩0 Mil(As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co Additional Paid-In Capital?


PharmaResearch Co's quarterly additional paid-in capital increased from Sep. 2023 (₩174,712 Mil) to Dec. 2023 (₩175,428 Mil) but then stayed the same from Dec. 2023 (₩175,428 Mil) to Mar. 2024 (₩0 Mil).

PharmaResearch Co's annual additional paid-in capital increased from Dec. 2021 (₩152,413 Mil) to Dec. 2022 (₩157,582 Mil) and increased from Dec. 2022 (₩157,582 Mil) to Dec. 2023 (₩175,428 Mil).


PharmaResearch Co Additional Paid-In Capital Historical Data

The historical data trend for PharmaResearch Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaResearch Co Additional Paid-In Capital Chart

PharmaResearch Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126,652.08 133,405.45 152,412.70 157,582.27 175,427.90

PharmaResearch Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 158,578.40 173,427.68 174,711.60 175,427.90 -

PharmaResearch Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

PharmaResearch Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PharmaResearch Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaResearch Co (XKRX:214450) Business Description

Traded in Other Exchanges
N/A
Address
74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co (XKRX:214450) Headlines

No Headlines